ArticlePloS one2026

Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage.

Akiyoshi Shimoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.